The authors thank the Kempe Foundation for an instrumen-
tation grant and SPV and DB acknowledge the Swedish
Research Council (SRC) for a project grant.
Notes and references
y Baseline physical characterization of neutral acesulfame shown to be
Form I.
z Crystallographic data for the acesulfame dimorphs (C H NO S,
4 5 4
M = 163.15, Kappa CCD, ꢂ123 1C). Form I: monoclinic, a =
˚
7
1
.4940(15), b = 11.784(2), c = 15.238(3) A, b = 101.36(3)1, V =
3
319.3(4) A , D = 1.643 g cm , space group = P2
ꢂ3
˚
1
/c, Z = 8,
Fig. 6 Energy–temperature diagram of an enantiotropic dimorphic
ꢂ1
m(Mo-Ka) = 0.443 mm , size 0.22 ꢄ0.18 ꢄ 0.13 mm. 9845 total
p f
system: G, free energy; H, enthalpy; T , transition temperature; T ,
reflections of which 5031 were independent, 4024 observed [I 4 2s(I)].
melting temperature.
2
Refinement against F with 183 parameters, R1 [I 4 2s(I)] = 0.0432,
wR2 = 0.1433. Form II: triclinic, a = 6.3310(2), b = 7.4720(3),
˚
c = 7.7150(15) A, a = 62.5460(15), b = 73.1710(18), g = 77.874(2)1,
Table 1 Physical properties of acesulfame, Forms I and II
3
V = 308.73(2) A , D = 1.755 g cm , space group = P1, Z = 2,
ꢂ3
˚
ꢀ
ꢂ1
Modification
Form I
Form II
m(Mo-Ka) = 0.473 mm , size 0.28 ꢄ0.26 ꢄ 0.18 mm. 1307 total
reflections of which 1307 were independent, 1256 observed [I 4 2s(I)].
a
2
M.p. (1C) DSC onset temp.
Enthalpy of transition/J g
—1 22.27 ꢁ 0.13
1.643
67.8
—
Refinement against F with 91 parameters, R1 [I 4 2s(I)] = 0.0313,
wR2 = 0.0910.
ꢂ1
ꢂ3
a
82.57 ꢁ 0.57
Calculated density/g cm
Packing co-efficient Ck*
True density/g cm
1.755
72.7
1
J. Bernstein, Polymorphism in Molecular Crystals, Clarendon Press,
Oxford, 2002; R. Hilfiker, in Polymorphism in the Pharmaceutical
Industry, Wiley-VCH, Weinheim, Germany, 2006; D. J. W. Grant, in
Polymorphism in Pharmaceutical Solids, ed. H. G. Brittain, Marcel
Dekker, Inc., New York, 1999, pp. 1–34; J. M. Aceves-Hernandez,
ꢂ3
b
b
1.6154 ꢁ 0.0021
1.7097 ꢁ 0.0094
Metastable
ꢂ29.83
Stability at 22 1C
Lattice energies/kcal mol
Stable
ꢂ28.25
ꢂ1
a
b
n = 3 determinations. n = 10 determinations, true densities of
Forms I and II are significantly different (T-test, p o0.05).
I. Nicola
´
V. M. Castan
s-Va
´
zquez, F. J. Aceves, J. Hinojosa-Torres, M. Paz and
ˇ
o, J. Pharm. Sci., 2009, 98, 2448–2463; Z. Ma and
B. Moulton, J. Chem. Crystallogr., 2009, 39, 913–918.
C. C. Sun and D. J. W. Grant, Pharm. Res., 2001, 18, 274–280;
C. C. Sun, J. Pharm. Sci., 2009, 98, 1671–1687.
2
3
product phase from slurry studies (at room temperature (RT)
of about 22 1C) indicated that the Form II had transformed to
Form I. This result confirmed that the Form I is thermo-
dynamically more stable than the Form II in ambient con-
ditions and the transition temperature could be at or below
RT. Thus, adequate attention must be paid with respect to
evaluating the physical stabilities of enantiotropic polymorphs
at storage conditions.w
J. Bernstein, Nat. Mater., 2005, 4, 427–428; S. Karki, T. Fric
L. Fabian, P. R. Laity, G. M. Day and W. Jones, Adv. Mater.,
009, 21, 3905–3909.
ic,
ˇ ´
´
´
2
4
S. Basavoju, C. M. Reddy and G. R. Desiraju, Acta Crystallogr.,
Sect. E: Struct. Rep. Online, 2005, 61, o822–o823; C. M. Reddy,
K. A. Padmanabhan and G. R. Desiraju, Cryst. Growth Des., 2006,
6, 2720–2731; C. M. Reddy, M. T. Kirchner, R. C. Gundakaram,
K. A. Padmanabhan and G. R. Desiraju, Chem.–Eur. J., 2006, 12,
2
G. E. Dieter, Mechanical Metallurgy, SI Metric edn, McGraw-Hill,
222–2234.
The calculated densities and packing fractions were obtained
from the single crystal structures at ꢂ123 1C and true densities
for these forms were measured using a pychnometer at RT
5
Singapore, 1988, pp. 651–678.
6 C. M. Reddy, R. V. Gundakaram, S. Basavoju, M. T. Kirchner,
K. A. Padmanabhan and G. R. Desiraju, Chem. Commun., 2005,
(
Table 1). The calculated density of Form II was higher than
2
C. M. Reddy, R. V. Gundakaram, S. Basavoju, M. T. Kirchner,
439–2441.
that of Form I, which is in line with the close packing observed
in Form II. Lattice energy calculations further indicated that
7
8
K. A. Padmanabhan and G. R. Desiraju, Chem. Commun., 2005,
3
ꢂ1
945–3947.
the Form II had lower free energy (B1.6 kcal mol ) com-
J. H. Chu, in Handbook of Pharmaceutical Excipients, ed.
R. C. Rowe, P. J. Sheskey and S. C. Owen, American Pharma-
ceutical Association, Washington, D.C., 5th edn, 2006, pp. 4–5;
FAO/WHO, World Health Organ. Tech. Rep. Ser., 1991, No. 806.
pared to Form I at ꢂ123 1C, and therefore, Form II is
thermodynamically stable at ꢂ123 1C.w In fact, the stability
order has changed somewhere between ꢂ123 1C and RT as
indicated by equilibrium slurry studies. However, the density of
Form II was higher than that of Form I at ambient tempera-
ture. As cautioned in the literature, the density rule can deviate
9
A. A. Llina
98–210; W. Beckmann, Org. Process Res. Dev., 2000, 4, 372–383.
0 S. Basavoju, D. Bostrom and S. P. Velaga, Pharm. Res., 2008, 25,
530–541.
`
s and J. M. Goodman, Drug Discovery Today, 2008, 13,
1
1
¨
0
15
11 N. Zencirci, T. Gelbrich, D. C. Apperley, R. K. Harris,
V. Kahlenberg and U. J. Griesser, Cryst. Growth Des., 2010, 10,
for solids with Z a 1 which is the case for Form I.
In conclusion, the two polymorphic forms of acesulfame
sweetener were discovered and unequivocally characterized.
One of these aliphatic polymorphs showed bending (Form I)
and the other was brittle (Form II) in nature. The bending
phenomenon in Form I is very well correlated to the layered
structure. Forms I and II were enantiotropically related. Form I
is thermodynamically more stable than Form II in ambient
conditions. Future prospects are to investigate the influence
of mechanical properties (bending/brittle) on the powder
compaction or tableting behaviour.
3
02–313.
1
1
2 A. Burger and R. Ramberger, Mikrochim. Acta, 1979, II,
259–272; A. Burger and R. Ramberger, Mikrochim. Acta, 1979,
II, 273–316.
3 L. Yu, J. Pharm. Sci., 1995, 84, 966–974; K. Kawakami, J. Pharm.
ndez and
J. A. Ellena, J. Pharm. Sci., 2006, 95, 1075–1083.
Sci., 2007, 96, 982–989; D. Vega, A. Petragalli, D. Ferna
´
14 Y. Hu, H. Wikstro
¨
m, S. R. Byrn and L. S. Taylor, J. Pharm.
Biomed. Anal., 2007, 45, 546–551.
1
5 C. C. Sun, J. Pharm. Sci., 2007, 96, 1043–1052; S. Thirunahari,
S. Aitipamula, P. S. Chow and R. B. H. Tan, J.Pharm. Sci., 2010,
DOI: 10.1002/jps.22061.
3
564 | Chem. Commun., 2010, 46, 3562–3564
This journal is ꢀc The Royal Society of Chemistry 2010